Media Thread, page-2845

Good morning and I hope everyone is having a great Sunday even though most of us are in lockdown. Being all excited with what is in store for this great company via our great management team I just wanted to write down what has happened in the last couple of months and what's in store for us going forward. I wanted to write it down in a summary for my own sanity and to share it with all the others to know where we're at . Apart from the major announcements that have occurred in the last couple of months in terms of partnerships which are ,
1. City of hope for the next four years which are fully paid for
2. Celularity
3. 95 million capital raising from both cornerstone investors and most notably loyal shareholders which I might add was oversubscribed
There is a lot to look forward to. The financial review has written a detailed article regarding Wesfarmers and how it believes that it's going from good to great . In the article , the CEO pointed out and I'm quoting' You know what I'm pleased about is we've got a lot of irons in the fire for the future 'and this comment just pleased me in as far as it is similar in where I think Imugene can go and the story it's embarking on . I've stated previously we have various platforms with we should be excited about and here they are ,
1. B Cell Immunotherapy which consists of Hervaxx and PD1VAXX
2. CF 33 Oncolytic virus which consists of CHECK VAXX and Vaxinia
3. Oncarlytics which combines CF33- CD19 ( to treat solid tumours which makes up 90% of the cancer market )
I'd like to apologise in advance if I've missed anything in my brief summary but I'm Just pointing out that Imugene also has a lot of irons in the fire for the future and with patience and trust in Leslie , Paul , Yuman and the rest of them the future looks extremely bright and exciting. Thank you and I hope this piece will bring more excitement and positivity.